{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:25:43Z","timestamp":1759335943812,"version":"3.44.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T00:00:00Z","timestamp":1731196800000},"content-version":"am","delay-in-days":375,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.bulcan.2023.02.030","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T10:14:28Z","timestamp":1689243268000},"page":"1106-1115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["SMD & LMMC\u00a0: diagnostic et classification"],"prefix":"10.1016","volume":"110","author":[{"given":"Orianne","family":"Wagner-Ballon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6021-4057","authenticated-orcid":false,"given":"Olivier","family":"Kosmider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2017","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","key":"10.1016\/j.bulcan.2023.02.030_bib0185"},{"issue":"4","key":"10.1016\/j.bulcan.2023.02.030_bib0190","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","article-title":"Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group","volume":"33","author":"Bennett","year":"1976","journal-title":"Br J Haematol"},{"year":"2001","series-title":"World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues","key":"10.1016\/j.bulcan.2023.02.030_bib0195"},{"year":"2008","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","key":"10.1016\/j.bulcan.2023.02.030_bib0200"},{"issue":"7","key":"10.1016\/j.bulcan.2023.02.030_bib0205","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.bulcan.2023.02.030_bib0210","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2023.02.030_bib0215","first-page":"7","article-title":"Revue microscopique du frottis sanguin\u00a0: propositions du Groupe Francophone d\u2019H\u00e9matologie Cellulaire (GFHC)","volume":"317","author":"Genevi\u00e8ve","year":"2014","journal-title":"Feuill Biol"},{"issue":"4","key":"10.1016\/j.bulcan.2023.02.030_bib0220","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.leukres.2013.12.020","article-title":"Proposal for refining the definition of dysgranulopoiesis in acute myeloid leukemia and myelodysplastic syndromes","volume":"38","author":"Goasguen","year":"2014","journal-title":"Leuk Res"},{"issue":"11","key":"10.1016\/j.bulcan.2023.02.030_bib0225","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3324\/haematol.13405","article-title":"Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts","volume":"93","author":"Mufti","year":"2008","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.bulcan.2023.02.030_bib0230","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/bjh.15435","article-title":"Dyserythropoiesis in the diagnosis of the myelodysplastic syndromes and other myeloid neoplasms: problem areas","volume":"182","author":"Goasguen","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bulcan.2023.02.030_bib0235","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.leukres.2016.04.009","article-title":"Quality control initiative on the evaluation of the dysmegakaryopoiesis in myeloid neoplasms: difficulties in the assessment of dysplasia","volume":"45","author":"Goasguen","year":"2016","journal-title":"Leuk Res"},{"issue":"27","key":"10.1016\/j.bulcan.2023.02.030_bib0240","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and Severe adult-onset autoinflammatory disease","volume":"383","author":"Beck","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.bulcan.2023.02.030_bib0245","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00277-014-2252-4","article-title":"Interobserver variance in myelodysplastic syndromes with less than 5% bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2% blasts","volume":"94","author":"Font","year":"2015","journal-title":"Ann Hematol"},{"issue":"7","key":"10.1016\/j.bulcan.2023.02.030_bib0250","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3324\/haematol.2008.005421","article-title":"Morphological evaluation of monocytes and their precursors","volume":"94","author":"Goasguen","year":"2009","journal-title":"Haematologica"},{"issue":"26","key":"10.1016\/j.bulcan.2023.02.030_bib0255","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.bulcan.2023.02.030_bib0260","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.bulcan.2023.02.030_bib0265","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/nm.3733","article-title":"Age-related mutations associated with clonal hematopoietic expansion and malignancies","volume":"20","author":"Xie","year":"2014","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.bulcan.2023.02.030_bib0270","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000489042","article-title":"ICUS, IDUS, CHIP and CCUS: diagnostic criteria, separation from MDS and clinical implications","volume":"86","author":"Valent","year":"2019","journal-title":"Pathobiology"},{"issue":"7939","key":"10.1016\/j.bulcan.2023.02.030_bib0275","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41586-022-05448-9","article-title":"Common and rare variant associations with clonal haematopoiesis phenotypes","volume":"612","author":"Kessler","year":"2022","journal-title":"Nature"},{"year":"2022","series-title":"Prediction of risk for myeloid malignancy in clonal hematopoiesis abstract 926 ASH","author":"Weeks","key":"10.1016\/j.bulcan.2023.02.030_bib0280"},{"key":"10.1016\/j.bulcan.2023.02.030_bib0285","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1200\/JCO.2011.35.6394","article-title":"New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge","volume":"30","author":"Schanz","year":"2012","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.bulcan.2023.02.030_bib0290","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1038\/s41375-022-01652-8","article-title":"High-resolution structural variant profiling of myelodysplastic syndromes by optical genome mapping uncovers cryptic aberrations of prognostic and therapeutic significance","volume":"36","author":"Yang","year":"2022","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.bulcan.2023.02.030_bib0295","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/ijc.33942","article-title":"Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML\/MDS patients","volume":"150","author":"Gerding","year":"2022","journal-title":"Int J Cancer"},{"issue":"9","key":"10.1016\/j.bulcan.2023.02.030_bib0300","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41408-022-00718-1","article-title":"Optical genome mapping refines cytogenetic diagnostics, prognostic stratification and provides new molecular insights in adult MDS\/AML patients","volume":"12","author":"Balducci","year":"2022","journal-title":"Blood Cancer J"},{"issue":"5","key":"10.1016\/j.bulcan.2023.02.030_bib0305","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41591-021-01367-w","article-title":"Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes","volume":"27","author":"Bernard","year":"2021","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.bulcan.2023.02.030_bib0310","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200008","article-title":"Molecular International Prognostic Scoring System for Myelodysplastic Syndromes","volume":"1","author":"Bernard","year":"2022","journal-title":"NEJM Evid"},{"issue":"1","key":"10.1016\/j.bulcan.2023.02.030_bib0315","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/cyto.b.22105","article-title":"Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by the ELN iMDS flow working group","volume":"104","author":"Kern","year":"2023","journal-title":"Cytometry B Clin Cytom"},{"issue":"8","key":"10.1016\/j.bulcan.2023.02.030_bib0320","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3324\/haematol.2011.048421","article-title":"Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study","volume":"97","author":"Della Porta","year":"2012","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.bulcan.2023.02.030_bib0325","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3324\/haematol.2014.112755","article-title":"Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic\/myeloproliferative neoplasms","volume":"100","author":"Bardet","year":"2015","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.bulcan.2023.02.030_bib0330","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1038\/leu.2013.178","article-title":"Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes","volume":"27","author":"Mathis","year":"2013","journal-title":"Leukemia"},{"issue":"23","key":"10.1016\/j.bulcan.2023.02.030_bib0335","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1182\/blood-2015-01-620781","article-title":"Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia","volume":"125","author":"Selimoglu-Buet","year":"2015","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.bulcan.2023.02.030_bib0340","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1182\/blood-2016-12-753210","article-title":"Monocyte subset analysis accurately distinguishes CMML from MDS and is associated with a favorable MDS prognosis","volume":"129","author":"Talati","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bulcan.2023.02.030_bib0345","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/cyto.b.22054","article-title":"ELN iMDS flow working group validation of the monocyte assay for chronic myelomonocytic leukemia diagnosis by flow cytometry","volume":"104","author":"Wagner-Ballon","year":"2023","journal-title":"Cytometry B Clin Cytom"},{"issue":"12","key":"10.1016\/j.bulcan.2023.02.030_bib0350","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.bulcan.2023.02.030_bib0355","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1182\/blood-2016-07-728766","article-title":"Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes","volume":"128","author":"Greenberg","year":"2016","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.bulcan.2023.02.030_bib0180","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.3324\/haematol.2019.222059","article-title":"Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions","volume":"104","author":"Valent","year":"2019","journal-title":"Haematologica"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455123002849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455123002849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:38:05Z","timestamp":1757792285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455123002849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0007455123002849"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2023.02.030","relation":{},"ISSN":["0007-4551"],"issn-type":[{"type":"print","value":"0007-4551"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SMD & LMMC\u00a0: diagnostic et classification","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2023.02.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}